1. Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.
- Author
-
Höchsmann, Britta, Yoshiko Murakami, Makiko Osato, Knaus, Alexej, Michi Kawamoto, Norimitsu Inoue, Tetsuya Hirata, Shogo Murata, Anliker, Markus, Eggermann, Thomas, Jäger, Marten, Floettmann, Ricarda, Höllein, Alexander, Sho Murase, Yasutaka Ueda, Jun-ichi Nishimura, Yuzuru Kanakura, Nobuo Kohara, Schrezenmeier, Hubert, and Krawitz, Peter M.
- Subjects
- *
PAROXYSMAL hemoglobinuria , *MYELOPROLIFERATIVE neoplasms , *BLOOD cells , *CELL populations , *CELL membranes - Abstract
Patients with paroxysmal nocturnal hemoglobinuria (PNH) have a clonal population of blood cells deficient in glycosylphosphatidylinositol-anchored (GPI-anchored) proteins, resulting from a mutation in the X-linked gene PIGA. Here we report on a set of patients in whom PNH results instead from biallelic mutation of PIGT on chromosome 20. These PIGT-PNH patients have clinically typical PNH, but they have in addition prominent autoinflammatory features, including recurrent attacks of aseptic meningitis. In all these patients we find a germ-line point mutation in one PIGT allele, whereas the other PIGT allele is removed by somatic deletion of a 20q region comprising maternally imprinted genes implicated in myeloproliferative syndromes. Unlike in PIGA-PNH cells, GPI is synthesized in PIGT-PNH cells and, since its attachment to proteins is blocked, free GPI is expressed on the cell surface. From studies of patients' leukocytes and of PIGT-KO THP-1 cells we show that, through increased IL-1β secretion, activation of the lectin pathway of complement and generation of C5b-9 complexes, free GPI is the agent of autoinflammation. Eculizumab treatment abrogates not only intravascular hemolysis, but also autoinflammation. Thus, PIGT-PNH differs from PIGA-PNH both in the mechanism of clonal expansion and in clinical manifestations. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF